How Cochlear Implant Rehabilitation Impacts the Therapeutic Strategy for Vestibular Schwannoma.
cochlear implant
hearing rehabilitation
neurofibromatosis
vestibular schwannoma
Journal
Audiology research
ISSN: 2039-4330
Titre abrégé: Audiol Res
Pays: Switzerland
ID NLM: 101644681
Informations de publication
Date de publication:
08 Feb 2023
08 Feb 2023
Historique:
received:
03
12
2022
revised:
30
01
2023
accepted:
02
02
2023
entrez:
24
2
2023
pubmed:
25
2
2023
medline:
25
2
2023
Statut:
epublish
Résumé
Since both surgery and more conservative treatments show long-term outcomes in patients with VS, the current challenge in its therapeutic strategy is to offer a cure with lower functional morbidity in terms of facial and hearing preservation or the possibility of hearing rehabilitation with a cochlear implant. PubMed and Scopus databases were searched from 2017 to November 2022. Fifteen articles met our selection criteria: (1) patients with a diagnosis of VS, either sporadic or NF2-related; (2) simultaneous or sequential cochlear implantation; (3) specified audiological test results and follow-up timing. Although the level of evidence for the presently included studies is low due to either the study design or the lack of treatment consensus, CI rehabilitation is a promising option, especially in small VS with compromised hearing and as a salvage option after a failed attempt at hearing preservation surgery.
Sections du résumé
BACKGROUND
BACKGROUND
Since both surgery and more conservative treatments show long-term outcomes in patients with VS, the current challenge in its therapeutic strategy is to offer a cure with lower functional morbidity in terms of facial and hearing preservation or the possibility of hearing rehabilitation with a cochlear implant.
METHODS
METHODS
PubMed and Scopus databases were searched from 2017 to November 2022. Fifteen articles met our selection criteria: (1) patients with a diagnosis of VS, either sporadic or NF2-related; (2) simultaneous or sequential cochlear implantation; (3) specified audiological test results and follow-up timing.
CONCLUSIONS
CONCLUSIONS
Although the level of evidence for the presently included studies is low due to either the study design or the lack of treatment consensus, CI rehabilitation is a promising option, especially in small VS with compromised hearing and as a salvage option after a failed attempt at hearing preservation surgery.
Identifiants
pubmed: 36825950
pii: audiolres13010012
doi: 10.3390/audiolres13010012
pmc: PMC9952590
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
116-129Références
Laryngoscope. 2021 Jul;131(7):E2312-E2317
pubmed: 33851722
Otol Neurotol. 2022 Sep 1;43(8):962-967
pubmed: 35941713
Audiol Neurootol. 2016;21(5):286-295
pubmed: 27816972
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2763-2767
pubmed: 32909061
Audiol Res. 2022 Jan 10;12(1):33-41
pubmed: 35076488
Laryngoscope. 2020 Jun;130(6):E407-E415
pubmed: 31643090
Otol Neurotol. 2020 Oct;41(9):1190-1197
pubmed: 32925835
Otol Neurotol. 2017 Dec;38(10):1512-1516
pubmed: 29099442
Cochlear Implants Int. 2020 Jan;21(1):9-17
pubmed: 31496442
Otol Neurotol. 2003 Jul;24(4):642-8; discussion 648-9
pubmed: 12851559
Otol Neurotol. 2016 Jul;37(6):647-53
pubmed: 27273407
Otolaryngol Head Neck Surg. 2022 Jul;167(1):149-154
pubmed: 34546801
Otol Neurotol. 2012 Aug;33(6):1046-52
pubmed: 22805104
Audiol Neurootol. 2021;26(6):414-424
pubmed: 33789270
Acta Otorhinolaryngol Ital. 2020 Oct;40(5):390-395
pubmed: 33299230
J Int Adv Otol. 2021 May;17(3):265-268
pubmed: 34100754
Braz J Otorhinolaryngol. 2019 Jan - Feb;85(1):111-120
pubmed: 29980446
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):353-362
pubmed: 32504199
Acta Otorhinolaryngol Ital. 2018 Feb;38(1):56-60
pubmed: 29187758
J Int Adv Otol. 2021 Sep;17(5):452-460
pubmed: 34617898
Otolaryngol Head Neck Surg. 2022 Aug;167(2):209-214
pubmed: 34464224
Hear Res. 2022 May;418:108458
pubmed: 35334332
Otol Neurotol. 2015 Jul;36(6):972-6
pubmed: 25634466
J Neurol Surg B Skull Base. 2021 Jun 08;82(6):643-651
pubmed: 34745832
Audiol Res. 2022 Aug 07;12(4):414-422
pubmed: 36004950
Otol Neurotol. 2017 Oct;38(9):1339-1344
pubmed: 28796091
Am J Otolaryngol. 2020 Jul - Aug;41(4):102518
pubmed: 32451290
Neurosurgery. 2012 Feb;70(2):278-82; discussion 282
pubmed: 21808214
Neuro Oncol. 2020 Jan 11;22(1):31-45
pubmed: 31504802
Otol Neurotol. 2014 Jun;35(5):821-5
pubmed: 24608375
Otolaryngol Head Neck Surg. 2007 May;136(5):773-7
pubmed: 17478214
J Neurosurg. 2013 Mar;118(3):579-87
pubmed: 23101446
Neurosurgery. 2018 Nov 1;83(5):858-870
pubmed: 29281097
Eur Arch Otorhinolaryngol. 2022 Oct;279(10):4709-4718
pubmed: 35018505
Clin Otolaryngol. 2021 Nov;46(6):1223-1228
pubmed: 34080297
Ann Otol Rhinol Laryngol. 2020 Dec;129(12):1229-1238
pubmed: 32551844
Auris Nasus Larynx. 2019 Feb;46(1):78-82
pubmed: 30042019
J Neurol Surg B Skull Base. 2019 Apr;80(2):187-195
pubmed: 30931227
Laryngoscope. 2021 Mar;131(3):E759-E763
pubmed: 32692872
Otol Neurotol. 2020 Jan;41(1):e83-e88
pubmed: 31743296
Eur Arch Otorhinolaryngol. 2020 Feb;277(2):333-342
pubmed: 31802225
J Neurosurg. 1998 Mar;88(3):506-12
pubmed: 9488305
J Neurosurg. 2011 Oct;115(4):820-6
pubmed: 21682562
J Neurosurg. 2018 Jul;129(1):128-136
pubmed: 28820301